Angeliq (drospirenone, estradiol)
Jump to navigation
Jump to search
Introduction
Trademark: Angeliq
Indications
- treatment of menopausal symptoms
Adverse effects
- drospirenone may increase of venous thromboembolism[2]
Mechanism of action
- combination progestin/estrogen Manufacturers: Berlex
More general terms
Components
References
- ↑ Prescriber's Letter 13(2): 2006 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=220215&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 2.0 2.1 FDA Safety Alert: Posted 05/31/2011 Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm257337.htm